rs12722698

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000417.3(IL2RA):​c.753C>T​(p.Ile251Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00307 in 1,613,914 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 71 hom., cov: 31)
Exomes 𝑓: 0.0016 ( 65 hom. )

Consequence

IL2RA
NM_000417.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.36

Publications

5 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-6018094-G-A is Benign according to our data. Variant chr10-6018094-G-A is described in ClinVar as Benign. ClinVar VariationId is 300251.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0567 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000417.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
NM_000417.3
MANE Select
c.753C>Tp.Ile251Ile
synonymous
Exon 7 of 8NP_000408.1P01589
IL2RA
NM_001308242.2
c.537C>Tp.Ile179Ile
synonymous
Exon 6 of 7NP_001295171.1Q5W005
IL2RA
NM_001308243.2
c.465C>Tp.Ile155Ile
synonymous
Exon 5 of 6NP_001295172.1H0Y5Z0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
ENST00000379959.8
TSL:1 MANE Select
c.753C>Tp.Ile251Ile
synonymous
Exon 7 of 8ENSP00000369293.3P01589
IL2RA
ENST00000379954.5
TSL:1
c.537C>Tp.Ile179Ile
synonymous
Exon 6 of 7ENSP00000369287.1Q5W005
IL2RA
ENST00000447847.2
TSL:1
c.465C>Tp.Ile155Ile
synonymous
Exon 5 of 6ENSP00000402024.2H0Y5Z0

Frequencies

GnomAD3 genomes
AF:
0.0167
AC:
2541
AN:
152106
Hom.:
69
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0585
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00602
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00862
GnomAD2 exomes
AF:
0.00451
AC:
1133
AN:
251014
AF XY:
0.00362
show subpopulations
Gnomad AFR exome
AF:
0.0626
Gnomad AMR exome
AF:
0.00307
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.00164
AC:
2394
AN:
1461690
Hom.:
65
Cov.:
31
AF XY:
0.00139
AC XY:
1010
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.0587
AC:
1963
AN:
33462
American (AMR)
AF:
0.00353
AC:
158
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000414
AC:
46
AN:
1111890
Other (OTH)
AF:
0.00341
AC:
206
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
125
251
376
502
627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0168
AC:
2557
AN:
152224
Hom.:
71
Cov.:
31
AF XY:
0.0169
AC XY:
1260
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0587
AC:
2436
AN:
41514
American (AMR)
AF:
0.00601
AC:
92
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68020
Other (OTH)
AF:
0.00853
AC:
18
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
126
253
379
506
632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00674
Hom.:
31
Bravo
AF:
0.0184
Asia WGS
AF:
0.00664
AC:
24
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Immunodeficiency due to CD25 deficiency (2)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.3
DANN
Benign
0.77
PhyloP100
2.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12722698; hg19: chr10-6060057; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.